Lupin Unit Boosts Philippines Stake in $39.6M Multicare Pharma Deal

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Lupin Unit Boosts Philippines Stake in $39.6M Multicare Pharma Deal
Overview

Lupin Ltd. is increasing its stake in the Philippines. Its Dutch unit, Nanomi B.V., will buy an additional 43.38% of Multicare Pharmaceuticals Philippines, Inc. (MPPI) for up to $39.6 million. This acquisition aims to improve Lupin's market position, integrate operations more deeply, and create long-term value. The deal is expected to close by May 2026.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Expanding Philippines Operations

Lupin Ltd. is strengthening its foothold in the Philippine pharmaceutical market. Its wholly-owned Dutch subsidiary, Nanomi B.V., has agreed to buy 11,794,497 shares of Multicare Pharmaceuticals Philippines, Inc. (MPPI), representing a 43.38% stake.

This move aims to enhance Lupin's market position and help integrate MPPI's operations. Nanomi B.V. already owns a majority 56.28% stake in MPPI, which handles trading, importing, marketing, and distributing pharmaceutical products and medical devices in the Philippines. The new purchase will bring Lupin's consolidated ownership in MPPI close to full control, allowing for greater strategic flexibility and unlocking long-term value.

Deal Terms and Timeline

The deal involves a cash payment of up to $39.6 million. Lupin confirmed the acquisition is a related party transaction and has received approval from its audit committee. No promoters or their groups have a direct interest in this deal. Ernst & Young Merchant Banking Services LLP provided a valuation report to ensure the transaction is at fair market value.

Completion is targeted for the end of May 2026, once certain conditions are met. This expansion highlights Lupin's commitment to growing its international business and increasing its share in key emerging markets.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.